RX Now

Company NameProduct NameArchive typesAnnouncementView PDFDIN #
Pharmasciencepms-SitagliptinNew Product | Nouveau produitWe are pleased to announce the launch of pms-SITAGLIPTIN!02503840
SandozRivastigmine capsulesDiscontinuation | Abandon de produitSandoz Canada wishes to inform you that Sandoz Rivastigmine capsules will be no longer available upon depletion of inventory. 00000
PharmascienceDuloxetine 30mg 1000 CAPSNew pack size | Nouveau formatPharmascience Canada is please to announced the launch of a new large format for the following products: pms-DULOXETINE 30mg CAPS 1000, you may place your order now.2429446
PharmasciencePalbociclib New Product | Nouveau produitNew product launch of pms-Palbociclib.02552132
Pharmascience pms-DULOXETINE 60mg CAPS 500 New pack size | Nouveau formatPharmascience Canada is please to announced the launch of a new large format for the following product: pms-DULOXETINE 60mg CAPS 500, you may place your order now.2429454
SandozAlendronate, Dimethyl Fumarate, Finasteride Discontinuation | Abandon de produitSandoz Canada wishes to inform you that the following products will be no longer available upon depletion of inventory.0000000
Pharmasciencepms-DAPAGLIFLOZINProduct Appearance Up date | Nouvel aspect du produitWe would like to inform you of the change in appearance of pms-DAPAGLIFOZIN 5MG & 10MG. Please take a few minutes to review the information below.02531550
SandozSandoz BilastineNew Product | Nouveau produitWe are glad to share the launch of PrSandoz® Bilastine02536269
SandozPr SANDOZ® FESOTERODINE FUMARATEProduct Availability | Disponibilité des produitsSandoz Canada wishes to inform you that the following product Pr SANDOZ® FESOTERODINE FUMARATE 8 MG 100 TABLETS will be unavailable for an indefinite period of time. Rest assured; we are doing our utmost to ensure the continuity of supply of the replacement product Pr Sandoz® Fesoterodine fumarate 8mg in bottles of 30 tablets.02521776
PharmasciencePERIOSTATProduct Transition | Transition dans la productionWe are pleased to announce the commercial transfer of PERIOSTAT 20mg Capsules from Pendopharm to Pharmascience Canada effective October 15th, 2024.02247104
SandozSandoz AFAtinibNew Product | Nouveau produitWe are glad to share the launch of PrSandoz® AFAtinib.02512777
Pharmasciencepms-GABAPENTIN 100mg CAPS 1000New pack size | Nouveau formatPharmascience Canada is please to announced the launch of a new large format for the following product: pms-GABAPENTIN 100mg CAPS 1000, you may place your order now. 02243446
PharmasciencePMS-AMLODIPINENew pack size | Nouveau formatPharmascience Canada is please to announced the launch of a new large format for the following products: pms-AMLODIPINE 5mg TABS 2000 / 10mg TABS 1000, you may place your order now.2284065
PharmascienceNone Selected
PharmasciencePMS-CLONAZEPAM-RProduct Transition | Transition dans la productionDear Customer, Pharmascience is pleased to announce the product change of PMS-CLONAZEPAM to PMS-CLONAZEPAM-R.02048701
Pharmasciencepms-Escitalopram 10mgProduct Availability | Disponibilité des produitsWe would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-Escitalopram 10mg blisters. Consequently we will be out of stock for an extended period of time02469243
Pharmasciencepms-ROSUVASTATIN 20mg TABS 1500New pack size | Nouveau formatDear Customer, Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-ROSUVASTATIN 20mg TABS 1500.02378558
SandozMultiple ProductsDiscontinuation | Abandon de produitDiscontinuation Notice Multiple products
PharmascienceNew pack size | Nouveau formatDear Customer, Pharmascience Canada is please to announced the relaunch of the following products: pms-DEFERASIROX (TYPE J) 90mg, 180mg and 360mg TABS 30 BTL, are now available and you may place your order now.2528290
SandozPrSandoz® DutasterideNew Product | Nouveau produitWe’re glad to share the return of PrSandoz® Dutasteride 0.5 mg available in blister packs of 30 and bottles of 100 capsules. 02424444
SandozSandoz® DesvenlafaxineNew Product | Nouveau produitWe’re glad to share the launch of Sandoz® Desvenlafaxine.02538415
SandozSandoz Rivastigmine PatchInformation Update | Mise à jour des renseignementsSandoz Canada wishes to inform you that a downloadable tool is available for your patients who take Sandoz® Rivastigmine Patch. The tool is a multiple-page digital patient diary (one page per week) that can be printed out. It contains instructions for administering PrSandoz® Rivastigmine Patch and a place to record their use. 02426293
SandozSandoz® BisoprololNew Product | Nouveau produitSandoz® Bisoprolol new strengths. We're glad to share the launch of Sandoz® Bisoprolol 1.25 mg and 2.5 mg. • NEW CONCENTRATIONS exclusive to Sandoz 1.25 mg and 2.5 mg. • Scored tablets in 2.5 mg, 5 mg and 10 mg strengths. • Concentrations clearly indicated on tablets. • All strengths available in bottles of 100 tablets. 02544245
SandozSandoz LisdexamfetamineNew Product | Nouveau produitWe are glad to share the launch of Sandoz® Lisdexamfetamine.02546248
Pharmasciencepms-TRAZODONENew pack size | Nouveau formatPharmascience Canada is please to announced the launch of a new large format for the following product: pms-TRAZODONE 50mg TABS 1500, you may place your order now.01937227
SandozSandoz® Gliclazide MR and Sandoz® PravastatinDiscontinuation | Abandon de produitDiscontinuation Notice Sandoz Canada wishes to inform you that we are discontinuing Sandoz® Gliclazide MR and Sandoz® Pravastatin. The products will be no longer available upon depletion of inventory (date communicated below is subjected to change). Please accept our apologies for any inconvenience this may cause. 02461323
SandozSandoz Docusate SodiumDiscontinuation | Abandon de produitDiscontinuation Notice Sandoz® Docusate Sodium
Pharmasciencepms-PERINDOPRIL 8mgNew pack size | Nouveau formatPharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-PERINDOPRIL 8mg TABS 1000.02470691
Pharmasciencepms-FLUOXETINE 20mg CAPSNew pack size | Nouveau formatPharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-FLUOXETINE 20MG CAPS 1000 and is now available to order.02177587
PharmasciencePERICHLOR 0.12% ORAL RINSEImportant Announcement | Annonce importanteEffective June 1st, 2024, the following products will be transferred from Pendopharm, division of Pharmascience Inc. to Pharmascience Inc.02493160
PharmascienceNone Selected
SandozNone Selected
Pharmasciencepms-ROSUVASTATIN 5mg TABS 3000New pack size | Nouveau formatPharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-ROSUVASTATIN 5mg TABS 3000.02378523
SandozSandoz Gliclazide MRProduct Availability | Disponibilité des produitsSee PDF02314177
SandozNYPOZINew Product | Nouveau produitNYPOZI (filgrastim) is now available! 02520990
SandozNYPOZI - ZIEXTENZONew Product | Nouveau produitNow offering the complete G-CSF portfolio 02520990
PharmascienceNone Selected
Pharmasciencepms-DICLOFENAC 1.5% SOL TOPI 60 mLProduct Availability | Disponibilité des produitsWe would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-DICLOFENAC 1.5% SOL TOPI 60 mL. Consequently we will be out of stock for an extended period of time.02356783
Pharmasciencepms-METHOTREXATE 50MG/MLNew Product | Nouveau produitPharmascience Canada is pleased to announce the launch of pms-METHOTREXATE 50MG/ML, you may place your order now.2539608
Pharmasciencepms-PERINDOPRIL-AMLODIPINENew Product | Nouveau produitPharmascience Canada is pleased to announce the launch of pms-PERINDOPRIL-AMLODIPINE, you may place your order now.02541696
Pharmasciencepms-CITALOPRAM HBR 40mg TAB 1100,New pack size | Nouveau formatPharmascience Canada is please to announced the launch of a new large format for the following product: pms-CITALOPRAM HBR 40mg TAB 1100, you may place your order now.02248011
SandozSandoz ApremilastNew pack size | Nouveau formatSandoz Apremilast Started Kit now available02529092
SandozSandoz OmeprazoleDiscontinuation | Abandon de produitDiscontinuation Notice Sandoz® Omeprazole 10 mg02296438
Pharmasciencepms-PREGABALIN 150mg 800New pack size | Nouveau formatDear Customer, Pharmascience Canada is pleased to announce the launch of a new large format for the following product: pms-PREGABALIN 150mg CAPS 800 and you may place your order now.2359634
Pharmasciencepms-LACTULOSE-PHARMA 667mg/mLProduct Transition | Transition dans la productionDear Customer, Pharmascience is pleased to announce the product change of pharma-LACTULOSE 667mg/mL 500mL to pms-LACTULOSE-PHARMA 667mg/mL 500mL and 1000mL, effective immediately.02247383
Pharmasciencepms-QUINAPRIL 40mg TABS 100Product Availability | Disponibilité des produitsDear client, Pharmascience Canada is pleased to announce that pms-QUINAPRIL 40mg TABS 100 is now back in stock and you may place your order now.02340585
PharmascienceSILDENAFIL 100mg Product Transition | Transition dans la productionPharmascience is pleased to announce the product change of SILDENAFIL 100mg TABS 30 to SILDENAFIL 100mg TABS BLI 1X 4, effective immediately.02317583
Pharmasciencepms-TERAZOSIN 2mg TABS 100Product Appearance Up date | Nouvel aspect du produitDear Customer, We would like to inform you of the change in appearance of pms-TERAZOSIN 2mg tablets. This change is effective immediately. Please take a few minutes to review the information below. 02243519
Pharmasciencepms-LITHIUM CARBONATE 300mg CAPS 100Product Availability | Disponibilité des produitsDear Customer, We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-LITHIUM CARBONATE 300mg CAPS 100. Consequently we will be out of stock for an extended period of time.02216140
Pharmasciencepms-PAZOPANIBNew Product | Nouveau produitNow available pms-PAZOPANIB 200 mg Antineoplastic Agent A generic equivalent to VOTRIENT02525666
Pharmasciencepms-MONTELUKAST CHEWNew pack size | Nouveau formatDear Customer, Pharmascience is pleased to announce the product change of pms-MONTELUKAST CHEW 4mg TABS BLI 3X10 to pms-MONTELUKAST CHEW 4mg TABS 100.02354977
SandozAmlodipine 2.5 mgNew pack size | Nouveau formatWe would like to inform you that Pr Sandoz ® Amlodipine 2.5 mg is now available in a bottle format of 500 tablets and available through wholesalers.02330474
PharmasciencePHARMASCIENCE NEW XL FORMATSNew pack size | Nouveau formatDear Customer, Pharmascience Canada is please to announced the launch of a new large format for the following products: pms-SERTRALINE HCL 100mg CAPS 800, pms-PREGABALIN 25mg CAPS 1400, pms-PREGABALIN 50mg CAPS 1000 and pms-ZOPICLONE 7.5mg and you may place your order now. Regards, Pharmascience Canada02244840, 02359596, 02359618, 02240606
PharmasciencePHARMASCIENCE NEW XL FORMATSNew pack size | Nouveau formatDear Customer, Pharmascience Canada is please to announced the launch of a new large format for the following products: pms-CITALOPRAM HBR 20mg TAB 2900, pms-PERINDOPRIL 4mg TAB 1500 and pms-PREGABALIN 75mg CAP 1400, you may place your order now. Best regards, Pharmascience Canada02248010, 02470683, 02359626
Pharmasciencepms-DIGOXIN 0.05mg/mL ORAL SOL 115mLProduct Transition | Transition dans la productionDear Customer, Pharmascience is pleased to announce the product change of TOLOXIN 0.05mg/mL ORAL SOL 115mL to pms-DIGOXIN 0.05mg/mL ORAL SOL 115mL, effective immediately. Best regards, Pharmascience Canada 02242320
PharmascienceNone Selected02533332
Pharmascience pms-CIPROFLOXACIN XLProduct Availability | Disponibilité des produitsDear Customer, We would like to inform you that we are currently experiencing difficulties in guaranteeing the supply of pms-CIPROFLOXACIN XL 500mg TABS 100. Consequently we will be out of stock for an extended period of time. 2416433
PharmascienceOLESTYR REGULAR & LIGHT POWDER (ORANGE)Important Announcement | Annonce importanteDear, This is to inform you that since August 16, our Olestyr Regular and sugar-free product (DINs 02210320 & 00890960) is no longer covered by the Régie d'Assurance Médicaments du Québec (RAMQ). We were obliged to remove these products from the List of Medicines for economic reasons. The non-viability of this product at the current reimbursement price established by the RAMQ has forced to adjust our price. For more information, please find attached the official communication for your ready reference. Please do not hesitate to contact us if you have any questions regarding this communication. Sincerely, Pharmascience Canada02210320, 00890960
PharmasciencePerindopril-IndapamideNew Product | Nouveau produitPharmascience is pleased to announce the launch of pms- PERINDOPRIL-INDAPAMIDE!02537990,02538008,02537982
SandozSandoz Diclofenac SRDiscontinuation | Abandon de produitDear Customer, Sandoz Canada Inc wishes to inform you that Sandoz Diclofenac SR 100 mg will be no longer available upon depletion of inventory. Please accept our apologies for any inconvenience this may cause. For more information, please contact your local Sandoz regional sales manager or call our customer service at 1 800 361 3062. Thank you for your understanding.02261944
Pharmasciencepmsc-METFORMIN 500mg and 850mgProduct Appearance Up date | Nouvel aspect du produitDear Customer, We would like to inform you of the change in appearance of pmsc-METFORMIN 500mg and 850mg tablets. These changes will be in effect by early September 2023. Please take a few minutes to review the information below. Regards, Pharmascience Canada02520303, 02520311
SandozSandoz® Losartan and Sandoz® Losartan HCTNew pack size | Nouveau formatWe would like to inform you that Sandoz® Losartan and Sandoz® Losartan HCT are now available in 30 tablet blister packs and are available through wholesalers. 02313340, 02313359, 02313375, 02362449, 02313383
Pharmasciencepms-RAMIPRIL-HCTZ 10/25mg TABSProduct Transition | Transition dans la productionDear Customer, Pharmascience is pleased to announce the product change of pms-RAMIPRIL-HCTZ 10/25mg TABS BL 2X15 to pms-RAMIPRIL-HCTZ 10/25mg TABS 100. Regards, Pharmascience Canada02342170
PharmascienceTOLOXIN 0.0625mg & 0.125ng TABS 250 to pms-DIGOXIN 0.0625mg & 0.125mg TABS 250Product Transition | Transition dans la productionDear Customer, PHARMASCIENCE is pleased to announce the product change of TOLOXIN 0.0625mg & 0.125mg tabs 250 to pms-DIGOXIN 0.0625mg & 0.125mg tabs 250, effective immediately. Regards, Pharmascience Canada02335700 & 02335719
SandozPr Daptomycin for injectionNew pack size | Nouveau formatPackaging change for Pr Daptomycin for injection02490838
SandozPr Gemcitabine injectionNew pack size | Nouveau formatNew packaging02412292
Pharmasciencepms-FLUTICASONE HFA 50mcg/ACT 120New Product | Nouveau produitHello All, We are pleased to announce the launch of pms- FLUTICASONE HFA 50mcg/ACT in Ontario and Quebec only. Regards, Pharmascience Canada 02503115, 02503123, 02503131
Pharmascience pms-QUINAPRIL 5mg, 10mg and 20mg TABS 100Product Availability | Disponibilité des produitsDear Customer, Pharmascience Canada is pleased to announce that pms-QUINAPRIL 5mg, 10mg and 20mg TABS 100 are now back in stock and you may place your order now. Best regards, Pharmascience Canada02340550, 02340569, 02340577
SandozSandoz SunitinibNew Product | Nouveau produitNew product NA
SandozSandoz DapagliflozinNew Product | Nouveau produitLaunch of Sandoz DapagliflozinNA
Pharmasciencepms-DapagliflozinNew Product | Nouveau produitPharmascience is pleased to announce the launch of pms- DAPAGLIFLOZIN!0231550,0231569
SandozPrClindamycin Injection USP-60mlProduct Availability | Disponibilité des produitsNow available02230535
Pharmasciencepms-CLARITHROMYCIN 250mg & 500mg TabsDiscontinuation | Abandon de produitDear Customer, After careful consideration of our product portfolio, the decision has been made to cease production of the pms-CLARITHROMYCIN 250mg & 500mg tabs 100 for the Canadian market effective immediately. These skus will be removed from our product catalogue. Please note that Pharmascience remains the owner of the product DIN's. Please accept our sincere apologies for any inconvenience that this may cause. Best regards, Pharmascience Canada02247573, 02247574
SandozSandoz AlfacalcidolNew Product | Nouveau produitSandoz is proud to announce the launch of Sandoz Alfacalcidol.02533316,02533324
Pharmasciencepms-PIRFENIDONENew Product | Nouveau produitWe are pleased to announce the launch of pms- PIRFENIDONE!02531526, 02531534
PharmascienceMETHOTREXATE Injection PFS 25mg/mLNew Product | Nouveau produitPharmascience is pleased to announce the launch of METHOTREXATE Injection PFS 25mg/mL. For more information on our product, please see the attachment. Please don’t hesitate to contact us should you have any questions.02422204
SandozSandoz Indomethacin & Sandoz ProchlorperazineImportant Announcement | Annonce importanteDear Customer, Sandoz wishes to inform you that on March 1, 2023, Sandoz and Odan entered into an asset purchase agreement whereby Sandoz is divesting PrSandoz® Indomethacin and PrSandoz® Prochlorperazine to Odan. This agreement includes DINs but excludes Sandoz current available inventories. Odan is a Canadian specialty pharmaceutical company, headquartered in Montreal, with fully integrated infrastructures for R&D, manufacturing and distribution and a market leader for suppositories. Due to production constraints at the current manufacturing plant, following the acquisition, Odan will begin the site transfer process to its facility in Montreal. This will cause a temporary supply disruption of the products for several months (see table below for more information.) Rest assured that Sandoz and Odan are working closely together to bring the products back on the market as soon as possible. Effective as of October 31, 2023, Odan will handle ordering, billing, shipping and returns relating to the Products. Prior to that date, Sandoz will remain responsible for all functions, including returns of the Products.02231799,02231800,00789720
SandozSandoz MontelukastProduct Appearance Up date | Nouvel aspect du produitDear Customer, Sandoz Canada Inc. would like to inform you that there will be an appearance change for PrSandoz® Montelukast 10 mg tablets upon depletion of current inventory. Please note that the UPC code will also change.02328593
Pharmasciencepmsc-ESOMEPRAZOLE DRNew Product | Nouveau produitPharmascience is proud to offer pmsc-ESOMEPRAZOLE DR now available in both strengths 20mg and 40mg!02528479,02528487
PharmascienceOCTASA 1600 mg, mesalamine delayed-release oral tabletsNew Product | Nouveau produitPendopharm, division of Pharmascience Inc., is pleased to announce the launch of OCTASA® 1600 mg effective immediately. OCTASA® 1600 mg (mesalamine [also known as 5-aminosalicylic acid (5-ASA)] delayed-release oral tablets) is indicated for the induction of remission of moderate active ulcerative colitis (UC). It’s the highest-strength mesalamine available in Canada, offering to your patients dosing simplicity and improving treatment adherence . Want to find out more about OCTASA® 1600 mg? Feel free to reach out to Pendopharm Medical Information: 1-888-550-6060 or medinfo@pendopharm.com 02529610
Pharmasciencepms-ATOMOXETINE 10mg TABSProduct Transition | Transition dans la productionDear Customer, Pharmascience is pleased to announce the product change of pms-ATOMOXETINE 10mg TABS BLI 2x15 to pms-ATOMOXETINE 10mg TABS BLI 3x10, effective immediately. To place an order for pms-ATOMOXETINE 10mg TABS BLI 3x10, please contact your preferred distributor. For any inquiries related to pms-ATOMOXETINE 10mg TABS BLI 3x10, please contact Pharmascience Customer Service at 1-800-340- 9735 or via email at customercarepms@pharmascience.com Best regards, Isabelle Bragoli Product Manager Pharmascience Canada02381028
Pharmasciencepms-MONTELUKAST CHEW 4mg TABS 100Product Transition | Transition dans la productionPlease see attached.02354977
Pharmasciencepms-MONTELUKAST CHEW 5mg TABS BLI 3X10Product Availability | Disponibilité des produitsPlease see attached.02354985
MylanDymistaInformation Update | Mise à jour des renseignementsHEADLINE: Therapy for Minor Ailment BODY: Dymista is indicated for the symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms in adults, adolescents, and children aged 6 years and older. READ MORE DYMISTA® is not recommended for use in children less than 6 years of age as safety and efficacy have not been established in this age group. Consult the Product Monograph at https://health-products.canada.ca/dpd-bdpp/index-eng.jsp for more information about conditions of clinical use, contraindications, warnings, precautions, adverse reactions, interactions and dosing. The Product Monograph is also available by calling 1-844-596-9526. 02432889
Pharmasciencepms-BETAHISTINEProduct Availability | Disponibilité des produitsPlease see attached.02330210, 02330237
Pharmasciencepmsc-VENLAFAXINE XRProduct Availability | Disponibilité des produitsPharmascience est heureux de vous annoncer le lancement de pmsc-VENLAFAXINE XR!02521466,02521482,02521474
Pharmasciencepms-CINACALCETNew Product | Nouveau produitPharmascience is proud to announce the launch of pms-CINACALCET!02517604,02517612,02517620
SandozSandoz SitagliptinNew Product | Nouveau produitLaunch of Sandoz SitagliptinNA
SandozSandoz Sitagliptin-Metformin New Product | Nouveau produitLaunch of Sandoz Sitagliptin-MetforminNA
TevaTEVA-CEFADROXIL, TEVA-TOPISONE (CREAM), TEVA-ALMOTRIPTANFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products are now listed as benefits on the Saskatchewan Formulary effective December 1, 2022.02235134, 00804991, 02434849
TevaTEVA-TOPISONE (CREAM)Formulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product will be listed as a benefit on the Prince Edward Island Pharmacare Formulary effective December 28, 2022.00804991
TevaTeva-Diltiazem XCNew Product | Nouveau produitIntroducing generic alternative to TIAZAC® XC02429322, 02429330, 02429349, 02429357
Apotexpms-QUETIAPINE 200mg TABS 500Product Transition | Transition dans la productionPlease see attached.00703486
Apotexpms-CLARITHROMYCIN 500mg TABS 250Product Transition | Transition dans la productionPlease see attached.02278561
TevaTeva-Diltiazem XCNew Product | Nouveau produitIntroducing Teva-Diltiazem XC - generic alternative to Tiazac XC02429322, 02429330, 02429349, 02429357
TevaFormulary Update | Mise à jour du formulaire345345
SandozSupeudol Product Availability | Disponibilité des produitsDear Customer, Sandoz Canada Inc. wishes to inform you that the following products will be unavailable upon the depletion of inventory and for an indeterminate period. Please accept our apologies for any inconvenience this may cause. For more information, please contact your local Sandoz Regional Manager or call our Customer Service at 1-800-361-3062. Thank you.00392480,00392472
SandozSandoz Prochlorperazine SuppositoryProduct Availability | Disponibilité des produitsDear Customer, Sandoz Canada Inc. wishes to inform you that the following product will be unavailable for an indeterminate period. Please accept our apologies for any inconvenience this may cause. For more information, please contact your local Sandoz Regional Manager or call our Customer Service at 1-800-361-3062. Thank you.00789720
Pharmasciencepms-METHOTREXATE 2.5mg bottles of 100'sNew Product | Nouveau produitLine extension: pms-METHOTREXATE 2.5mg bottles of 100's02170698
ApotexKleanLyteProduct Availability | Disponibilité des produitsKleanLyte Celebrating 1 year on the market! 80107241
SandozSandoz AmbrisentanNew Product | Nouveau produitNew launch0000
SandozSandoz Mycophenolate MofetilProduct Appearance Up date | Nouvel aspect du produitDear Customer, Sandoz Canada Inc. would like to announce a packaging improvement for PrSandoz® Mycophenolate Mofetil upon the depletion of current inventory. Please note that the UPC codes will also change. For more information, please contact your local Sandoz Regional Manager. Thank you.02320630,02313855
Apotexpms-IRBESARTAN 150mg 500Product Transition | Transition dans la productionPlease see attached 02317079
TevaTeva-ValsartanProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02356678
TevaTeva-PregabalinProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce a product line extension for Teva-Pregabalin.02361159, 02361175, 02361183, 02361205, 02361221, 02361248
TevaTEVA-TERIFLUNOMIDEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product is now available on the British Columbia Pharmacare Formulary as Special Authority effective July 7, 2022.02501090
TevaFormulary Update | Mise à jour du formulaire02501090
TevaTEVA-NAPROXEN SODIUM, TEVA-NAPROXEN SODIUM DSFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products are listed on the Ontario Drug Benefit Formulary as Off-Formulary Interchangeable (OFI) effective August 31, 2022.00778389, 02026600
TevaTeva-TeriflunomideFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product will be listed on the Manitoba Drug Benefits and Interchangeability Formulary under Part 3 Exception Drug Status effective September 20, 2022.02501090
Pharmasciencepharma-SIMVASTATIN 20mg TABS 500Product Transition | Transition dans la productionPlease see attached.02469995
Pharmasciencepms-ABACAVIR/LAMIVUDINE600/300mg T 3X10Product Availability | Disponibilité des produitsPlease see attached.02458381
TevaTEVA-FLUTICASONEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce the following product is now available on the Nova Scotia Formulary as interchangeable (not insured) effective September 12, 2022.02453738
TevaTEVA-TERIFLUNOMIDE, TEVA-DESVENLAFAXINEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products will be listed on the Manitoba Drug Benefits and Interchangeability Formulary under Part 3 Exception Drug Status effective September 20, 2022.02501090, 02458217, 02458225
Pharmasciencepms-DEFERASIROX FC (Type J)New Product | Nouveau produitPharmascience is proud to announce the launch of pms-DEFERASIROX FC (Type J)02528290/02528312
TevaTeva-PregabalinProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce a product line extension for Teva-Pregabalin.02361159, 02361175, 02361183, 02361205, 02361221, 02361248
Pharmasciencepms-SILDENAFIL R 20mg TABS BLI 6X15Product Transition | Transition dans la productionPlease see attached.02412179
MylanFULPHILA ONE CERTImportant Announcement | Annonce importanteImmediate financial assistance for FULPHILA patients at pharmacy for up to a maximum of 25% of total cost of product to the patient. 02484153
TevaTeva-PregabalinProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce a product line extension for Teva-Pregabalin.02361159, 02361175, 02361183, 02361205, 02361221, 02361248
TevaAermony RespiClick Information Update | Mise à jour des renseignementsAermony RespiClick 02467895, 02467909, 02467917
Pharmasciencepms-TERIFLUNOMIDE 14MGFormulary Update | Mise à jour du formulairepms-TERIFLUNOMIDE 14MG will be registered on the RAMQ list on Aug 17, 202202500434
TevaTEVA-TERIFLUNOMIDEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product is now available as a Special Authorization benefit on the New Brunswick Drug Plan Formulary effective June 30, 2022.02501090
TevaTEVA-TERIFLUNOMIDEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product is now available as a Special Authorization benefit on the Newfoundland and Labrador Drug Formulary effective July 1, 2022.02501090
TevaTeva-PregabalinProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce a product line extension for Teva-Pregabalin.02361159, 02361175, 02361175, 02361221, 02361248
TevaREVIAFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product is listed on the Alberta Drug Benefit Formulary effective July 1, 2022.02213826
Pharmasciencepms-ATORVASTATIN 10mg - 20mg - 40mgProduct Transition | Transition dans la productionPlease see the attached the communication for pms-ATORVASTATIN02399377-02399385-02399393
Pharmasciencepmsc-METFORMINNew pack size | Nouveau formatNEW FORMAT BOTTLE OF 360'S NOW AVAILABLE!02520303
Pharmasciencepms-CELECOXIB 200mgProduct Transition | Transition dans la productionPlease see attached.02355450
SandozSandoz Capsule June 2022Important Announcement | Annonce importanteNew formulary listings0000
SandozSandoz Capsule June 2022Important Announcement | Annonce importanteNew formulary listings0000
SandozSandoz Capsule June 2022Important Announcement | Annonce importanteNew formulary listings0000
ApotexNew Product Launch: Apo-Apixaban 2.5 mg & 5 mg TabsNew Product | Nouveau produitNew Product Launch: Apo-Apixaban 2.5 mg & 5 mg Tabs02487381, 02487403
TevaTeva-TeriflunomideNew Product | Nouveau produitGeneric alternative to AUBAGIO®02501090
TevaTEVA-TERIFLUNOMIDEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products are listed on the Nova Scotia Formulary under Exception Status, effective June 6, 2022.02501090
SandozMilrinone Lactate InjectionDiscontinuation | Abandon de produitNotice of Discontinuation 02244854
TevaOctreotide for Injectable SuspensionFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products will be listed on the Manitoba Drug Benefits and Interchangeability Formulary effective June 1, 2022.02503751, 02503778, 02503786
SandozSandoz Capsule May 2022Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz Capsule May 2022Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz Capsule May 2022Important Announcement | Annonce importanteNew formulary listings0000
TevaTeva-TeriflunomideNew Product | Nouveau produitGeneric alternative to AUBAGIO®02501090
ApotexOntario pan-Canadian Price Change: Effective May 31, 2022Price Update | Mise à jour des prixOntario pan-Canadian Price Change: Effective May 31, 20220
Pharmasciencepms-ABACAVIR/LAMIVUDINE 600/300mg TAB 30Product Availability | Disponibilité des produitsPlease see attached.02458381
SandozAcetylcysteine SolutionProduct Availability | Disponibilité des produitsNow available02243098
TevaTeva-TeriflunomideNew Product | Nouveau produitGeneric alternative to AUBAGIO®02501090
ApotexNew Product Launch: Apo-Teriflunomide 14 mg TabsNew Product | Nouveau produitNew Product Launch: Apo-Teriflunomide 14 mg Tabs02500639
SandozSandoz TeriflunomideNew Product | Nouveau produitNew launch0000
Pharmasciencepms-TeriflunomideNew Product | Nouveau produitPharmascience is proud to launch pms-Teriflunomide 02500434
SandozMethylphenidate SRDiscontinuation | Abandon de produitDiscontinuation02320312
SandozTopiramate TabDiscontinuation | Abandon de produitDiscontinuation02431807, 02431815, 02431823
Pharmasciencepmsc-METFORMIN New pack size | Nouveau formatPharmascience is now also offering pmsc-METFORMIN in a format of 360's! 02520303
ApotexManitoba pan-Canadian Price Change: Effective June 1, 2022Price Update | Mise à jour des prixManitoba pan-Canadian Price Change: Effective June 1, 20220
ApotexNova Scotia Formulary Update: Effective May 9, 2022Formulary Update | Mise à jour du formulaireNova Scotia Formulary Update: Effective May 9, 20220
ApotexSaskatchewan Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixSaskatchewan Price Change: Effective Immediately0
MylanIntroducing ABEVMYNew Product | Nouveau produitIntroducing ABEVMY (bevacizumab for injection)02522160, 02522179
Pharmasciencepms-VALPROIC ACID E.C 500MG TABSImportant Announcement | Annonce importantesee attachment02229628
SandozPiperacillin and TazobactamNew Product | Nouveau produitPiperacillin and Tazobactam 40.5g02521539
TevaTEVA-DESVENLAFAXINEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce the following products are listed on the Ontario Drug Benefit Formulary as Off-Formulary Interchangeable (OFI) effective April 29, 2022.02458217, 02458225
SandozSandoz Capsule April 2022Important Announcement | Annonce importanteNew listings0000
SandozSandoz Capsule April 2022Important Announcement | Annonce importantexxx000
SandozSandoz Capsule April 2022Important Announcement | Annonce importanteNew listings0000
SandozSandoz Capsule April 2022Important Announcement | Annonce importanteNew listings0000
MylanIntroducing ABEVMYNew Product | Nouveau produitIntroducing ABEVMY (bevacizumab for injection), Viatris' third oncology biosimilar for Canadian patients.02522160,02522179
MylanACCESSA and FulphilaImportant Announcement | Annonce importanteAccessa vous présente son programme de soutien aux patients (PSP) Fulphila en collaboration avec Viatris : une gamme de services adaptés aux besoins des patients dans un contexte de traitements de chimiothérapie. 02484153
MylanONE CERT for FulphilaImportant Announcement | Annonce importanteIntroducing, a multi-use and multi-patient group and certificate number for patients dispensed Fulphila.02484153
TevaTeva-DesvenlafaxineNew Product | Nouveau produitGeneric alternative to PRISTIQ02458217, 02458225
TevaTEVA-VALGANCICLOVIRInformation Update | Mise à jour des renseignementsPlease be informed that the following UPC is no longer available. The DIN remain the same for this product. New UPC and Item codes are listed below.02413825
TevaTEVA-DESVENLAFAXINEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce the following products are now available on the Nova Scotia Formulary as interchangeable (not insured) effective April 11, 2022.02458217, 02458225
TevaTEVA-DESVENLAFAXINEFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce the following products are listed on the Newfoundland and Labrador Interchangeable Drug Formulary effective April 1, 2022.02458217, 02458225
Apotexpms-ATOMOXETINE 18mg BLIS 2x15Product Transition | Transition dans la productionChange in packaging of pms-ATOMOXETINE 18mg BLIS 2x1502381036
SandozSandoz LurasidoneNew Product | Nouveau produitNew launch0000
Apotexpms-METFORMIN 850mgProduct Transition | Transition dans la productionPlease see attached.02242589
Apotexpms-METFORMIN 500mgProduct Transition | Transition dans la productionPlease see attached.02223562
ApotexMETONIA 5MG TABS 100 & METONIA 1mg/mL SOL 500mLProduct Transition | Transition dans la productionTransition Notice from METONIA 5MG TABS 100 & METONIA 1mg/mL SOL 500mL to pms-METOCLOPRAMIDE 5MG TABS & pms-METOCLOPRAMIDE 1mg/mL SOL 500mL 02230431 & 02230433
TevaTEVA-VALGANCICLOVIRInformation Update | Mise à jour des renseignementsPlease be informed that the following UPC is no longer available. The DIN remain the same for this product. New UPC and Item codes are listed below.02413825
Pharmasciencepharma-SIMVASTATIN 80MG BLISProduct Substitution | Substitution de produitTransition from pharma-SIMVASTATIN 80MG BLIS to pharma-SIMVASTATIN 80MG 10002470012
PharmasciencePANTOPRAZOLE 40MGProduct Transition | Transition dans la productionREMINDER - TRANSITION NOTICE PANTOPRAZOLE 40MG02437945
SandozSandoz Capsule March 2022Important Announcement | Annonce importanteNew formulary listings000
SandozCapsule Sandoz March 2022Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz Capsule March 2022Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz FinasterideProduct Appearance Up date | Nouvel aspect du produitProduct appearance change for Sandoz Finasteride 5mg.02322579
MylanFULPHILA ONE CERT ProgramImportant Announcement | Annonce importanteEffective immediately, the Fulphila copay program has moved to ONE CERT for all patients across the country adding additional efficiency to patient financial assistance. Click to learn more.02484153
SandozIsoproterenol Hydrochloride Injection USPProduct Availability | Disponibilité des produitsNow available00897639
TevaTeva OTC Allergy Products and First Aid SolutionsInformation Update | Mise à jour des renseignementsWith spring around the corner, help your patients find relief with Teva’s assortment of over-the-counter allergy products, as well as first aid solutions for itches and scratches. Our products maintain the quality you know and trust from Teva at competitive, low prices.00021288, 02097583, 02097583, 02097575
ApotexManitoba Price Change: Effective April 1, 2022Price Update | Mise à jour des prixManitoba Price Change: Effective April 1, 20220
TevaTEVA-ROSUVASTATINInformation Update | Mise à jour des renseignementsPlease be informed that the following UPCs are no longer available. The DINs remain the same for this product. Replacement codes are listed below.02354608, 02354616, 02354624, 02354632
TevaTeva-DesvenlafaxineNew Product | Nouveau produitGeneric alternative to PRISTIQ®02458217, 02458225
SandozFLUOXETINE CAPDiscontinuation | Abandon de produitDiscontinuation02479486, 02479494
Pharmasciencepms-LOSARTAN 25MG,50MG & 100MGProduct Availability | Disponibilité des produitsAvailable from Pharmascience pms-LOSARTAN 25MG,50MG & 100MG 02309750, 02309769 & 02309777
ApotexNewfoundland Price Change: Effective March 8, 2022Price Update | Mise à jour des prixNewfoundland Price Change: Effective March 8, 20220
SandozTRANSDERM-V (SCOPOLAMINE PATCH)Discontinuation | Abandon de produitDiscontinuation80024336
Pharmasciencepms-RISPERIDONE 3mg TABS BLI 6X10Product Transition | Transition dans la productionPlease see attached.02252058
Pharmasciencepms-RISPERIDONE 2mg TABS BLI 6X10Product Transition | Transition dans la productionPlease see attached.02252031
Pharmasciencepms-RISPERIDONE 3mg TABS 500Product Transition | Transition dans la productionPlease see attached.02252058
Pharmasciencepms-RISPERIDONE 2mg TABS 500Product Transition | Transition dans la productionPlease see attached.02252031
Pharmasciencepms-LOSARTAN 100mgProduct Availability | Disponibilité des produitsBack in Stock: pms-LOSARTAN 100mg02309777
ApotexOntario Price Change: Effective February 28. 2022 Price Update | Mise à jour des prixOntario Price Change: Effective February 28. 2022 0
ApotexNewfoundland and Labrador Formulary Update: Effective March 1, 2022Formulary Update | Mise à jour du formulaireNewfoundland and Labrador Formulary Update: Effective March 1, 20220
SandozBortezomib for Injection SDZNew Product | Nouveau produitNew launch02503352
ApotexNew Brunswick Price Change: Effective February 28, 2022Price Update | Mise à jour des prixNew Brunswick Price Change: Effective February 28. 20220
SandozComtan Discontinuation Discontinuation | Abandon de produitDiscontinuation0000
TevaACT RIZATRIPTANInformation Update | Mise à jour des renseignementsPlease be informed that the following UPCs are no longer available. The DINs remain the same for this product. Replacement codes are listed below.02381702
TevaTEVA-TELMISARTAN HCTZProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02330288, 02379252
SandozSandoz Capsule February 2022Important Announcement | Annonce importantenew formulary listings0000
SandozSandoz Capsule February 2022Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz Capsule February 2022Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz Capsule February 2022Important Announcement | Annonce importanteNew formulary listings0000
ApotexAlberta Price Change: Effective March 1, 2022Price Update | Mise à jour des prixAlberta Price Change: Effective March 1, 20220
TevaTeva-DesvenlafaxineNew Product | Nouveau produitGeneric Alternative to PRISTIQ®02458217, 02458225
TevaTEVA-ROSUVASTATINInformation Update | Mise à jour des renseignementsPlease be informed that the following UPCs are no longer available. The DINs remain the same for this product. Replacement codes are listed below.02354608, 02354616, 02354624, 02354632
TevaTeva-DesvenlafaxineNew Product | Nouveau produitIntroducing Teva-Desvenlafaxine - Generic alternative to Pr PRISTIQ (R)02458217, 02458225
ApotexNew Product Launch: Apo-Guanfacine XR 1 mg, 2 mg, 3 mg and 4 mg TabletsNew Product | Nouveau produitNew Product Launch: Apo-Guanfacine XR 1 mg, 2 mg, 3 mg and 4 mg Tablets02523728, 02523736, 02523744, 02523752
SandozSandoz ClonidineNew Product | Nouveau produitNew launch0000
SandozSandoz TramadolProduct Transition | Transition dans la productionProduct schedule change000
Pharmasciencepms-LOSARTAN 25mg & 50mgProduct Availability | Disponibilité des produitsBack in Stock: pms-LOSARTAN 25mg & 50mg02309750 & 02309769
TevaTeva-Telmisartan HCTZProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02330288, 02379252
TevaFormulary Update | Mise à jour du formulaire02230584, 02230585, 02503751, 02503778, 02503786
ApotexNIHB Formulary Update: Effective ImmediatelyFormulary Update | Mise à jour du formulaireNIHB Formulary Update: Effective Immediately0
ApotexAlberta Formulary Update: Effective February 1, 2022Formulary Update | Mise à jour du formulaireAlberta Formulary Update: Effective February 1, 202202505762
TevaTEVA-TELMISARTAN HCTZProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02330288
SandozSandoz Capsule January 2022Information Update | Mise à jour des renseignementsnew formulary listings0000
ApotexManitoba Formulary Update: February 24, 2022Formulary Update | Mise à jour du formulaireManitoba Formulary Update: February 24, 20220
Apotexpms-AMLODIPINE 10mgProduct Transition | Transition dans la productionSee attachment02469049
TevaTEVA-TELMISARTAN HCTZProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02330288
TevaOctreotide for Injectable SuspensionFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce the following products are listed on the Newfoundland and Labrador Drug Formulary effective January 1, 2022.02503751, 02503778, 02503786
SandozFer SuspensionDiscontinuation | Abandon de produitDiscontinuation02246590
TevaOCTREOTIDE FOR INJECTABLE SUSPENSIONFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product is now available on the New Brunswick Drug Plan Formulary effective December 15, 2021.02503751, 02503778, 02503786
TevaOctreotide for Injectable SuspensionFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce the following products have Exception Drug Status in Saskatchewan effective January 1, 2022.02503751, 02503778, 02503786
TevaOctreotide for Injectable SuspensionFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce the following products are now available on the Nova Scotia Formulary effective January 10, 2022.02503751, 02503778, 02503786
ApotexNewfoundland Price Change Update: Effective ImmediatelyPrice Update | Mise à jour des prixNewfoundland Price Change Update: Effective Immediately0
SandozSandoz Capsules December 2021Important Announcement | Annonce importanteNew formulary listings000
Pharmasciencepms-PROGESTERONE 200mg GELCAPS BLI 2X15Product Availability | Disponibilité des produitsPlease see attachment.02480247
Pharmasciencepms-HYDROMORPHONE 1mg/mL SYRUP 500mL Product Availability | Disponibilité des produitsPlease see attached.01916386
Pharmasciencepms-PROGESTERONE 100mg GELCAPS BLI 2X15Product Availability | Disponibilité des produitsPlease see attached.02476576
ApotexSaskatchewan Formulary Update: Effective ImmediatelyFormulary Update | Mise à jour du formulaireSaskatchewan Formulary Update: Effective Immediately0
TevaOCTREOTIDE FOR INJECTABLE SUSPENSIONFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that that following products are listed on the Alberta Drug Benefit Formulary as Special Authorization effective December 1, 2021.02503751, 02503778, 02503786
TevaLoestrinInformation Update | Mise à jour des renseignementsPlease be informed that the following pack size will be discontinued and no longer available.00353027
SandozSandoz Capsule December 2021Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz Capsules December 2021Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz Capsules December 2021Important Announcement | Annonce importanteNew formulary listings0000
Pharmasciencepms-ATORVASTATIN 80mgProduct Transition | Transition dans la productionsee attached02477173
PharmasciencePHARMA-AMLODIPINE 2.5mgProduct Transition | Transition dans la productionsee attached02469022
Pharmasciencepms-ATORVASTATIN 80mgProduct Transition | Transition dans la productionsee attached02477173
Pharmasciencepms-AMOLDIPINE 5mg & 10mgProduct Transition | Transition dans la productionPlease see attached02469030 & 02469049
TevaOctreotide for Injectable SuspensionNew Product | Nouveau produitIntroducing Octreotide for Injectable Suspension - First generic alternative to Sandostatin LAR®02503751, 02503778, 02503786
TevaOctreotide for Injectable SuspensionFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that that following products are listed on the Alberta Drug Benefit Formulary as Special Authorization effective December 1, 2021.02503751, 02503778, 02503786
TevaOctreotide for Injectable SuspensionFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that that following products are listed on the Ontario Drug Benefit Drug Formulary effective November 30, 202102503751, 02503778, 02503786
Pharmasciencepms-Metformin 850mg TABS 100Product Transition | Transition dans la productionPlease see attached.02242589
ApotexAlberta Price Change: Effective December 1, 2021Price Update | Mise à jour des prixAlberta Price Change: Effective December 1, 20210
ApotexSaskatchewan Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixSaskatchewan Price Change: Effective Immediately0
ApotexBritish Columbia Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixBritish Columbia Price Change: Effective Immediately0
TevaOCTREOTIDE FOR INJECTABLE SUSPENSIONFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that that following products are listed on the Alberta Drug Benefit Formulary as Special Authorization effective December 1, 2021.02503751, 02503778, 02503786
TevaOCTREOTIDE FOR INJECTABLE SUSPENSION None SelectedTeva Canada is pleased to announce that that following products are listed on the Ontario Drug Benefit Drug Formulary effective November 30, 2021.02503751, 02503778, 02503786
TevaOctreotide for Injectable SuspensionNone SelectedIntroducing first generic alternative to Sandostatin LAR®02503751, 02503778, 02503786
TevaTeva-TopileneInformation Update | Mise à jour des renseignementsPlease be informed that the following pack size will be discontinued and no longer available.01927914
SandozTrandolaprilProduct Appearance Up date | Nouvel aspect du produitAppearance ChangeNA
Pharmasciencepms-DESMOPRESSIN 0.2mgProduct Availability | Disponibilité des produitsPharmascience is pleased to announce the re-launch of pms-DESMOPRESSIN 0.2mg02304376
ApotexPrince Edward Island Formulary Update: Effective November 22, 2021Formulary Update | Mise à jour du formulairePrince Edward Island Formulary Update: Effective November 22, 20210
ApotexPrince Edward Island Price Change: Effective November 22, 2021None SelectedPrince Edward Island Price Change: Effective November 22, 20210
Pharma Sciencepms-CELECOXIB 100mg CAPS 100 and 500Product Transition | Transition dans la productionPlease see attached.02355442
TevaTEVA-BETAMETHASONE/CALCIPOTRIOLFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products will be listed on the Manitoba Drug Benefits and Interchangeability Formulary02427419, 02478307, 02478315, 02478323, 02478331, 02478358, 02466198
TevaOctreotide for Injectable SuspensionNew Product | Nouveau produitFirst generic alternative to PrSandostatin LAR®02503751, 02503778, 02503786
ApotexNova Scotia Price Change: Effective November 8, 2021Price Update | Mise à jour des prixNova Scotia Price Change: Effective November 8, 20210
ApotexSaskatchewan Price Change: Effective November 1, 2021 Price Update | Mise à jour des prixSaskatchewan Price Change: Effective November 1, 20210
ApotexNewfoundland Price Change: Effective November 1, 2021Price Update | Mise à jour des prixNewfoundland Price Change: Effective November 1, 20210
ApotexManitoba Price Change: Effective November 25, 2021Price Update | Mise à jour des prixManitoba Price Change: Effective November 25, 20210
MylanFULPHILA NOW LISTEDFormulary Update | Mise à jour du formulaireNow listed on the PEI Pharmacare Formulary under the High Cost & Catastrophic Drug Programs02484153
PharmascienceAsaphen Chew 80mgProduct Transition | Transition dans la productionPlease see attachment.02009013
Pharmasciencepms-SILODOSINNew Product | Nouveau produitPharmascience is proud to launch pms-SILODOSIN, a generic equivalent to Rapaflo02517779,02517787
Pharmasciencepms-EVEROLIMUSNew Product | Nouveau produitPharmascience is proud to launch pms-EVEROLIMUS, a generic equivalent to Afinitor02504677,02504685,02504693
ApotexAlberta Price Change: Effective November 1, 2021Price Update | Mise à jour des prixAlberta Price Change: Effective November 1, 20210
PharmascienceMYINFLA ER 0.5mgNew Product | Nouveau produitPlease see attachment.02519380
TevaTEVA-BETAMETHASONE/CALCIPOTRIOLFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products will be listed as Special Authorization on the Prince Edward Island Formulary effective October 25, 2021:02427419
TevaCEFAZOLIN SODIUM INJECTIONFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product is now available on the New Brunswick Drug Plan Formulary effective October 28, 2021.02108135
TevaHerzumaNew Product | Nouveau produitA Herceptin® (trastuzumab) biosimilar available in Canada02480794, 02506211
TevaTeva-Teriparatide injectableNone SelectedGeneric alternative to Forteo®02486423
TevaOctreotide for Injectable SuspensionNew Product | Nouveau produitFirst generic alternative to PrSandostatin LAR®02503751, 02503778, 02503786
SandozSandoz Capsule October 2021Important Announcement | Annonce importanteNew formulary listings0000
SandozSandoz Capsule October 2021Important Announcement | Annonce importanteNew formulary listings0000
Pharmasciencepms-NIFEDIPINE ER 30mgProduct Appearance Up date | Nouvel aspect du produit02418630
ApotexApotex National Order Desk 2021 Holiday HoursInformation Update | Mise à jour des renseignementsApotex National Order Desk 2021 Holiday Hours0
Pharmasciencepms-LEVETIRACETAMNew Product | Nouveau produitPharmascience is proud to relaunch pms-LEVETIRACETAM02296101, 02296128,02296136
TevaOctreotide for Injectable SuspensionNew Product | Nouveau produitIntroducing Octreotide for Injectable Suspension - First generic alternative to PrSandostatin LAR®02503751, 02503778, 02503786
TevaTEVA-IRBESARTAN HCTZProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following products to the Canadian market.02330512, 02330520, 02330539
TevaTEVA-IRBESARTANProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following products to the Canadian market.02316404, 02316412
TevaTEVA-BETAMETHASONE/CALCIPOTRIOLFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products will be listed as Special Authorization on the Prince Edward Island Formulary effective October 25, 202102427419
TevaTeva-Teriparatide InjectionFormulary Update | Mise à jour du formulaireApproved by Health Canada as an interchangeable generic to Forteo® Now listed and fully reimbursed on RAMQ!02486423
Pharmasciencepms-ATOMOXETINE 10mg Product Availability | Disponibilité des produitsPlease see attachment 02381028
TevaTeva-Metoprolol UncoatedProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02261898
ApotexBritish Columbia Price Change: Effective October 21, 2021Price Update | Mise à jour des prixBritish Columbia Price Change: Effective October 21, 20210
ApotexNova Scotia Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixNova Scotia Price Change: Effective Immediately0
PharmascienceMYINFLANew Product | Nouveau produitPlease see attached.02519380
SandozTIMOLOL SDZ 0.5% 5ML EGEL CAProduct Availability | Disponibilité des produitsProduct Availability02242276
SandozDimethyl Fumarate LaunchNew Product | Nouveau produitNew launch announcement0000
Pharmasciencepms-DIMETHYL FUMARATENew Product | Nouveau produitPharmascience is proud to launch pms-DIMETHYL FUMARATE, a generic equivalent to Tecfidera ®. Please see attached for more information including patient support program.02497026,02497034
ApotexNational Price Change: Effective October 1, 2021Price Update | Mise à jour des prixNational Price Change: Effective October 1, 20210
ApotexOntario Price Change: Effective September 30, 2021Price Update | Mise à jour des prixOntario Price Change: Effective September 30, 20210
ApotexManitoba Price Change: Effective October 1, 2021Price Update | Mise à jour des prixManitoba Price Change: Effective October 1, 20210
ApotexNewfoundland Price Change: Effective October 1, 2021Price Update | Mise à jour des prixNewfoundland Price Change: Effective October 1, 20210
ApotexAlberta Price Change: Effective October 1, 2021Price Update | Mise à jour des prixAlberta Price Change: Effective October 1, 20210
ApotexOntario Price Change: Effective October 1, 2021Price Update | Mise à jour des prixOntario Price Change: Effective October 1, 20210
ApotexNew Brunswick Price Change: Effective September 30, 2021Price Update | Mise à jour des prixNew Brunswick Price Change: Effective September 30, 20210
TevaTeva-Teriparatide InjectionFormulary Update | Mise à jour du formulaireApproved by Health Canada as an interchangeable generic to Forteo®02486423
TevaIrbesartan HCTZProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02330512, 02330520, 02330539
TevaIrbesartanProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02316404, 02316412
TevaMetoprolol UncoatedProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02261898
Pharmasciencepms-DESMOPRESSIN 0.1mgProduct Availability | Disponibilité des produitsPharmascience is proud to relaunch pms-DESMOPRESSIN 0.1 mg02304368
SandozImipenem/Cilastatin for Injection USP 250/250MGDiscontinuation | Abandon de produitDiscontinuation02358336
PharmasciencePMS-NITROFURANTOIN BID 100mg CAPS 100Product Appearance Up date | Nouvel aspect du produitPlease see attachment.02455676
Pharmasciencepms-METHOTREXATE 2.5mg TABS BLI 3X10Price Update | Mise à jour des prixPlease see attachment.02170698
ApotexNova Scotia Formulary Update: Effective September 6, 2021Formulary Update | Mise à jour du formulaireNova Scotia Formulary Update: Effective September 6, 20210
ApotexSaskatchewan Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixSaskatchewan Price Change: Effective Immediately0
ApotexSaskatchewan Formulary Update: Effective September 1, 2021Formulary Update | Mise à jour du formulaireSaskatchewan Formulary Update: Effective September 1, 20210
ApotexNew Brunswick Formulary Update: Effective ImmediatelyFormulary Update | Mise à jour du formulaireNew Brunswick Formulary Update: Effective Immediately0
ApotexSaskatchewan Price Change: Effective September 1, 2021Price Update | Mise à jour des prixSaskatchewan Price Change: Effective September 1, 20210
SandozFER CFDiscontinuation | Abandon de produitDiscontinuation02241802
SandozTIMOLOL SDZ 0.25% 5ML EGEL CAProduct Availability | Disponibilité des produitsPRODUCT AVAILABILITY02242275
SandozSandoz Capsule September 2021Important Announcement | Annonce importanteNew formulary listings0000
SandozSandoz Capsule September 2021Important Announcement | Annonce importanteNew formulary listings0000
TevaTeva-DasatinibFormulary Update | Mise à jour du formulaireTeva Canada a le plaisir d’annoncer que le produit suivant figurera sur la Liste des médicaments du Québec à compter du 18 août, 202102478307, 02478315, 02478323, 02478358
TevaTeva-RosuvastatinProduct Transition | Transition dans la productionTeva-Rosuvastatin will be transitioning to a new tablet appearance02354608, 02354616, 02354624, 02354632
TevaTeva-Simvastatin, Teva-TolterodineProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following products to the Canadian market.02299593, 02299607, 02250152
SandozTOBRAMYCIN INHDiscontinuation | Abandon de produitDiscontinuation02443368
TevaTeva-Tolterodine; Teva-SimvastatinProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following products to the Canadian market.02299593, 02299607, 02250152
TevaTeva-RosuvastatinProduct Transition | Transition dans la productionTeva-Rosuvastatin will be transitioning to a new tablet appearance02354608, 02354616, 02354624, 02354632
ApotexBritish Columbia Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixBritish Columbia Price Change: Effective Immediately0
ApotexOntario Formulary Update: Effective August 31, 2021Formulary Update | Mise à jour du formulaireOntario Formulary Update: Effective August 31, 20210
ApotexOntario Price Change: Effective August 31, 2021Price Update | Mise à jour des prixOntario Price Change: Effective August 31, 20210
SandozSandoz Capsule August 2021Important Announcement | Annonce importanteNew formulary listing000
SandozSandoz Capsule August 2021Important Announcement | Annonce importanteNew formulary listing000
SandozSandoz Capsule of August 2021Important Announcement | Annonce importantenew formulary listing000
TevaTeva-DasatinibFormulary Update | Mise à jour du formulaire02478307, 02478315, 02478323, 02478358
SandozCi-Cal D Discontinuation | Abandon de produitDiscontinuation80030816
ApotexSaskatchewan Price Change: Effective August 1, 2021Price Update | Mise à jour des prixSaskatchewan Price Change: Effective August 1, 20210
ApotexNew Brunswick Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixNew Brunswick Price Change: Effective Immediately0
ApotexNew Brunswick Price Change: Effective July 29, 2021None SelectedNew Brunswick Price Change: Effective July 29, 20210
Apotexpms-ESCITALOPRAMNew Product | Nouveau produitPharmascience launches pms-ESCITALOPRAM02469243,02469251
TevaTeva-RosuvastatinProduct Transition | Transition dans la productionTeva-Rosuvastatin will be transitioning to a new tablet appearance: -DIN’s will remain the same. -Item and UPC numbers will change as the product transitions.02354608, 02354616, 02354624, 02354632
TevaTeva-TolterodineProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following product to the Canadian market.02299593, 02299607
SandozDICLOFENAC SR 75MGDiscontinuation | Abandon de produitDiscontinuation2261901
Sandoz CyproheptadineDiscontinuation | Abandon de produitDiscontinuation02245668
Apotexpms-METOCLOPRAMIDE HYDROCHLORIDE INJECTIONNew Product | Nouveau produitPharmascience is pround to announce the launch of pms- METOCLOPRAMIDE HYDROCHLORIDE INJECTION.02510790
TevaTEVA-BETAMETHASONE/CALCIPOTRIOLFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product is now available as a Special Authorization benefit on the New Brunswick Drug Plan Formulary effective July 15, 2021.02427419
MylanFULPHILA CODIFICATION NOTICEInformation Update | Mise à jour des renseignementsEffective June 25, 2021, coding for the exception drug pegfilgrastim is possible if the clinical condition of the insured person corresponds to the recognized payment indications under code HE359.02484153
SandozSandoz Capsule July 2021Important Announcement | Annonce importanteNew formulary listings0000
SandozSandoz capsule July 2021Important Announcement | Annonce importantexxx000
SandozSandoz Capsule July 2021Important Announcement | Annonce importanteNew formulary listings 0000
SandozOrphenadrineProduct Availability | Disponibilité des produitsProduct availability 02243559
TevaAct RizatriptanProduct Transition | Transition dans la productionAct Rizatriptan 10 mg tablets will be transitioning to new codes: -Product Name, DIN and appearance will remain the same. -Item, UPC, and wholesaler codes will change as the product transitions.02381702
TevaTeva- Cephalexin Susp, Teva-Anastrozole, Teva-Zopiclone, Teva-Bupropion XL, Teva-Buprenorphine/Naloxone, Teva-CephalexinProduct Appearance Up date | Nouvel aspect du produitTeva Canada is pleased to announce the following product transitions to the Teva label. The products are now available for sale. The description on your invoices and packing slips will now align to the description on the new label. Only the label look will change to “Teva”. UPC, DIN, item code, product appearance and markings will remain the same.00342092, 02394898, 02242481, 02439654, 02439662, 02453908, 00342084
TevaTeva-Buprenorphine/Naloxone, Teva-CephalexinProduct Appearance Up date | Nouvel aspect du produitTeva Canada is pleased to announce the following product transitions to the Teva label. The product is now available for sale. The description on your invoices and packing slips will now align to the description on the new label. Only the label look will change to “Teva”. UPC, DIN, item code, product appearance and markings will remain the same.02453908, 00342084
TevaAct RizatriptanProduct Transition | Transition dans la productionAct Rizatriptan 10 mg tablets will be transitioning to a new formulation: -Product Name, DIN and appearance will remain the same. -Item, UPC, and wholesaler codes will change as the product transitions.02381702
Pharmasciencepms-METHOTREXATE 2.5mg BLI 3X10New pack size | Nouveau formatFormat change from blister 4X25 to 3X1002170698
ApotexApobiologix® Quebec Price Change: Lapelga® 6 mg/0.6 mL Sterile Solution for InjectionPrice Update | Mise à jour des prixApobiologix® Quebec Price Change: Lapelga® 6 mg/0.6 mL Sterile Solution for Injection02474565
ApotexNewfoundland Price Change: Effective July 1, 2021Price Update | Mise à jour des prixNewfoundland Price Change: Effective July 1, 20210
ApotexNew Brunswick Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixNew Brunswick Price Change: Effective Immediately0
ApotexSaskatchewan Price Change: Effective July 1, 2021Price Update | Mise à jour des prixSaskatchewan Price Change: Effective July 1, 20210
ApotexBritish Columbia Price Change: Effective July 15, 2021Price Update | Mise à jour des prixBritish Columbia Price Change: Effective July 15, 20210
ApotexNova Scotia Price Change: Effective July 12, 2021Price Update | Mise à jour des prixNova Scotia Price Change: Effective July 12, 20210
TevaTeva-DasatinibFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products are now available as a Special Authorization benefit on the Newfoundland Drug Formulary effective July 1, 2021.02478307, 02478315, 02478323, 02478331, 02478358
TevaNone Selected02466198
Pharmasciencepms-AMLODIPINEProduct Appearance Up date | Nouvel aspect du produitpms-AMLODIPINE is now available - New format and product appearance. See attached sell sheet for more information.02295148, 02284065,02284073
ApotexPrince Edward Island Price Change: Effective June 28, 2021Price Update | Mise à jour des prixPrince Edward Island Price Change: Effective June 28, 20210
ApotexNewfoundland Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixNewfoundland Price Change: Effective Immediately0
ApotexNIHB Formulary Update: Effective ImmediatelyFormulary Update | Mise à jour du formulaireNIHB Formulary Update: Effective Immediately0
TevaTeva-Dasatinib, Teva-FebuxostatFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product will be listed as Special Authorization on the Prince Edward Island Formulary effective June 28, 2021:02478307, 02478315, 02478323, 02478358, 02466198
SandozSandoz Capsule June 2021Important Announcement | Annonce importanteNew formulary listing0000
SandozSandoz Capsule June 2021None SelectedNew formulary listing0000
SandozSandoz Capsule June 2021Important Announcement | Annonce importanteNew formulary listings000
SandozSandoz Capsule June 2021Important Announcement | Annonce importanteNew formulary listings000
ApotexOntario Price Change: Effective June 30, 2021Price Update | Mise à jour des prixOntario Price Change: Effective June 30, 20210
TevaTeva-Dasatinib, Teva-FebuxostatFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products are now available as a Special Authorization benefit on the New Brunswick Drug Plan Formulary effective June 30, 2021.02478307, 02478315, 02478323, 02478331, 02478358, 02466198
TevaTeva-Zopiclone, Teva Bupropion XLProduct Appearance Up date | Nouvel aspect du produitTeva Canada is pleased to announce the following product transitions to the Teva label. The product is now available for sale. The description on your invoices and packing slips will now align to the description on the new label. Only the label look will change to “Teva”. UPC, DIN, item code, product appearance and markings will remain the same.02242481, 02439654, 02439662
TevaACT RizatriptanProduct Transition | Transition dans la productionAct Rizatriptan 10 mg tablets will be transitioning to a new formulation: - Product Name, DIN and appearance will remain the same. - Item, UPC, and wholesaler codes will change as the product transitions. - The 6 UDs will be transitioning immediately, followed by the 12 UDs02381702
TevaTeva-Pindolol, Teva-ZopicloneProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following products to the Canadian market. We are now ready to accept all orders.00869007, 00869015, 02246534, 02242481
MylanFULPHILA PRICE CHANGEPrice Update | Mise à jour des prixFULPHILA PRICE CHANGE02484153
ApotexBritish Columbia Price ChangesPrice Update | Mise à jour des prixBritish Columbia Price Changes0
ApotexNew Brunswick Price Change: Effective ImmediatelyPrice Update | Mise à jour des prixNew Brunswick Price Change: Effective Immediately0
TevaTeva-Pindolol, Teva-ZopicloneProduct Availability | Disponibilité des produitsTeva Canada is pleased to announce the availability of the following products to the Canadian market. We are now ready to accept all orders. 00869007, 00869015, 02246534, 02242481
TevaTeva-RosuvastatinProduct Transition | Transition dans la productionTeva-Rosuvastatin will be transitioning to a new tablet appearance:  DIN’s will remain the same.  Item and UPC numbers will change as the product transitions.  The 5 mg, 20mg, 40mg will begin transitioning immediately, followed by the 10 mg.02354608, 02354624, 02354632
TevaTeva-Febuxostat, Teva-NabiloneFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following products are now available on the British Columbia Pharmacare Formulary effective June 3, 2021.02466198, 02392925
TevaTeva-Dasatinib, Teva-FebuxostatFormulary Update | Mise à jour du formulaireTeva Canada is pleased to announce that the following product is now available under Special Authorization in the Nova Scotia Formulary effective June 7, 2021.02478307, 02478315, 02478323, 02478358, 02466198
TevaTEVA-TOPISONEProduct Appearance Updateratio-TOPISONE has been transitioned to TEVA-TOPISONE.Missing Attachment809187
ApotexApo-Lansoprazole-Amoxicillin-Clarithromycin 30 mg DR Caps, 500 mg Caps, 500 mg TabsFormulary UpdateApo-Lansoprazole-Amoxicillin-Clarithromycin 30 mg DR Caps, 500 mg Caps, 500 mg Tabs2,470,780
ApotexProduct Discontinuation: September 27, 2018DiscontinuationProduct Discontinuation: September 27, 20180
ApotexProduct Pack Discontinuation: September 20, 2018DiscontinuationProduct Pack Discontinuation: September 20, 20180
TevaMethoxisal - MethoxacetDiscontinuationThe following back pain products are no longer available and are discontinued.Missing Attachment2,236,872,019,663,750,000,000,000,000,000
TevaAllernixDiscontinuationThe following antihistamine products will be discontinued an no longer available.Missing Attachment209,758,302,097,575
SandozSandoz LacosamideNew ProductNew Product Sandoz Lacosamide2,474,670,024,746,890,000,000,000,000,000
TevaTeva-LacosamideNew ProductA generic alternative to Vimpat®.Missing Attachment2,472,902,024,729,100,000,000,000,000,000
ApotexApo-Emtricitabine-Tenofovir 200/300 mg TabsPrice UpdateApo-Emtricitabine-Tenofovir 200/300 mg Tabs2,452,006
TevaACT QUETIAPINEProduct TransitionTEVA-QUETIAPINE has been transitioned to ACT QUETIAPINE.Missing Attachment231,608,002,316,099,000,000,000,000,000,000,000,000
TevaACT PIOGLITAZONEProduct TransitionACT PIOGLITAZONE has been transitioned to ACT PIOGLITAZONE.Missing Attachment230,286,102,302,888,000,000,000,000,000,000,000,000
TevaTeva-TrandolaprilNew ProductA generic alternative to Mavik®Missing Attachment2,415,429,024,154,370,000,000,000,000,000
TevaTEVA-TOLTERODINE LAFormulary UpdateTEVA-TOLTERODINE LA, previously covered as Special Access will now be covered as a Regular Benefit effective October 1, 2018.Missing Attachment241,219,502,412,209
TevaTEVA-SOLIFENACINFormulary UpdateTEVA-SOLIFENACIN, previously covered as Special Access will now be covered as a Regular Benefit effective October 1, 2018.Missing Attachment239,790,002,397,919
TevaTEVA-ARIPIPRAZOLEFormulary UpdateTEVA-ARIPIPRAZOLE will be listed on the Ontario Drug Benefit Formulary effective September 27th.Missing Attachment246,417,902,464,179
SandozSandoz EsomeprazoleNew ProductNew Product Sandoz Esomeprazole246,092,002,460,939
MylanPyridoxine Hydrochloride InjectionImportant AnnouncementThis is to confirm that the product below has not been discontinued and is currently available to order.2,245,215
SandozHaloperidol LAProduct AvailabilityAnticipated backorder of Sandoz Haloperidol LA (decanoate) 100 mg/mL 5 mL vials9,999,999
SandozHaloperidol LAProduct AvailabilityAnticipated backorder of Sandoz Haloperidol LA (decanoate) 100 mg/mL 5 mL vials9,999,999
ApotexApo-Pinaverium 50 mg & 100 mg tabletsNew ProductApo-Pinaverium 50 mg & 100 mg tablets246,967,702,469,685
SandozSandoz Capsule at a GlanceFormulary UpdateFormulary & Launch Update – Ontario24,687,000,246,871,900,000,000
ApotexApo-Lansoprazole-Amoxicillin-Clarithromycin 30 mg DR Caps, 500 mg Caps, 500 mg TabsFormulary UpdateApo-Lansoprazole-Amoxicillin-Clarithromycin 30 mg DR Caps, 500 mg Caps, 500 mg Tabs2470780
ApotexBritish Columbia Price Change: Effective September 11, 2018Price UpdateBritish Columbia Price Change: Effective September 11, 20180
TevaTeva-AripiprazoleNew ProductGeneric alternative to Abilify®.Missing Attachment246,414,402,464,152,000,000,000,000,000,000,000,000
ApotexBritish Columbia Formulary Update: September 7, 2018Formulary UpdateBritish Columbia Formulary Update: September 7, 20180
ApotexApo-Efavirenz-Emtricitabine-Tenofovir 600 mg / 200 mg / 300 mg TabsNew ProductApo-Efavirenz-Emtricitabine-Tenofovir 600 mg / 200 mg / 300 mg Tabs2,468,247
TevaTEVA-ARIPIPRAZOLEFormulary UpdateTEVA-ARIPIPRAZOLE has been listed on the British Columbia Pharmacare Formulary.Missing Attachment246,417,902,464,187
ApotexApo-Solifenacin 5 mg & 10 mg TabsNew ProductApo-Solifenacin 5 mg & 10 mg Tabs242,337,502,423,383
ApotexApo-Metronidazole 500 mg CapsPrice UpdateApo-Metronidazole 500 mg Caps2,248,562
SandozSandoz RanitidineProduct Appearance UpdateAppearance change224,322,902,243,230

Author Agreement

In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Academy website (the “Website”), you (“You”) expressly agree to the following:

Review: MDBriefCase is pleased to consider the publication of Your Work on the Website.   The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.   

Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered.  If posted, You will be identified as the author of the Work, or co-author if applicable.  

Grant of Rights:  As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats:  (1) the exclusive right of first publication worldwide;  (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications.  The grant of rights survives termination or expiration of this Agreement.    

Warranty:  You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work.  This warranty survives termination or expiration of this Agreement.

Submission Agreement

Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Academy website.

Audience and Appropriate Topics

The  Healthcare Leadership Academy welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished.  When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.

Parameters

Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.

Length of Submissions

Guest articles for the MDBriefCase Healthcare Leadership Academy may run between 500 and 1000 words. 

Review

MDBriefCase reserves the right to accept or reject any submission  and the right to condition acceptance upon revision of material to conform to its criteria.   

No Compensation

There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal  websites, corporate websites and social media platforms.

Author Agreements

Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement